Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________________________________________________________________________________________________________ FORM 10-Q ____________________________________________________________________________________________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 29, 2025 ...

Plexus (PLXS) Q2 2025 Earnings Call April 25, 2025 12:48 AM ET Company Participants Shawn Harrison - Vice President - IRTodd Kelsey - President & CEOOliver Mihm - Executive VP & COOPatrick Jermain - EVP & CFOMelissa Fairbanks - Vice PresidentSteven Fox - Founder & CEORuben Roy - Managing Director - Equity ResearchChris Grenga - Equity Research AssociateSteve Barger - Managing Director - Equity Research Conference Call Participants David Williams - Equity Research AnalystAnja Soderstrom - Senior Equity Resea ...

FISCAL SECOND QUARTER 2025 HIGHLIGHTS April 23, 2025 PLEXUS CONFIDENTIAL SAFE HARBOR AND FAIR DISCLOSURE STATEMENT Some of the statements made and information provided during our call as well as information included in the supporting materials will be forward looking statements, including, without limitation, those regarding revenue, gross margin, selling and administrative expense, operating margin, other income and expense, taxes, cash cycle, capital allocation and future business outlook. Forward-looking ...

Plexus Corp. (NASDAQ:PLXS) Q2 2025 Earnings Conference Call April 24, 2025 8:30 AM ET Company Participants Shawn Harrison - Vice President, Investor Relations Todd Kelsey - President & Chief Executive Officer Oliver Mihm - Executive Vice President & Chief Operating Officer Pat Jermain - Executive Vice President & Chief Financial Officer Conference Call Participants David Williams – Benchmark Melissa Fairbanks - Raymond James Steven Fox - Fox Advisors LLC Ruben Roy - Stifel Jim Ricchiuti - Needham & Company ...

Plexus Corp (PLXS) reported second-quarter fiscal 2025 adjusted earnings per share (EPS) of $1.66, compared with year-ago quarter’s earnings of $1.19 per share. The figure outpaced the Zacks Consensus Estimate of $1.54 per share. Management expected non-GAAP EPS to be in the band of $1.46-$1.61.Revenues of $980.2 million improved 1.4% year over year and missed the Zacks Consensus Estimate of $980.5 million. Management expected revenues to be between $960 million and $1 billion. Increases in Healthcare/Life ...

Core Insights - Plexus reported revenue of $980.17 million for the quarter ended March 2025, reflecting a year-over-year increase of 1.4% [1] - The company's EPS was $1.66, significantly higher than the $0.94 reported in the same quarter last year, indicating strong earnings growth [1] - The revenue slightly missed the Zacks Consensus Estimate of $980.47 million by 0.03%, while the EPS exceeded the consensus estimate of $1.54 by 7.79% [1] Revenue Performance by Sector - Healthcare/Life Sciences sector generated revenue of $411 million, surpassing the average estimate of $407.10 million, with a year-over-year increase of 8.4% [4] - Aerospace/Defense sector reported revenue of $172 million, slightly below the estimated $174.10 million, marking a year-over-year increase of 1.2% [4] - Industrial sector revenue was $397 million, falling short of the estimated $399.55 million, representing a year-over-year decrease of 5% [4] Stock Performance - Plexus shares have returned -6.1% over the past month, compared to a -6.6% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]

Group 1 - Plexus reported quarterly earnings of $1.66 per share, exceeding the Zacks Consensus Estimate of $1.54 per share, and showing a significant increase from $0.94 per share a year ago, representing an earnings surprise of 7.79% [1] - The company posted revenues of $980.17 million for the quarter ended March 2025, slightly missing the Zacks Consensus Estimate by 0.03%, but showing growth from $966.9 million year-over-year [2] - Plexus has surpassed consensus EPS estimates in all four of the last quarters, but has only topped revenue estimates once during the same period [2] Group 2 - The stock has underperformed, losing about 20.7% since the beginning of the year, compared to a decline of 10.1% for the S&P 500 [3] - The current consensus EPS estimate for the upcoming quarter is $1.74 on revenues of $1.03 billion, and for the current fiscal year, it is $6.90 on revenues of $4.08 billion [7] - The Zacks Industry Rank for Electronics - Manufacturing Services is in the top 14% of over 250 Zacks industries, indicating a favorable outlook for the sector [8] Group 3 - The estimate revisions trend for Plexus is mixed, resulting in a Zacks Rank 3 (Hold), suggesting the stock is expected to perform in line with the market in the near future [6] - Celestica, another company in the same industry, is expected to report quarterly earnings of $1.11 per share, reflecting a year-over-year increase of 29.1%, with revenues projected at $2.55 billion, up 15.3% from the previous year [9][10]

Financial Performance - Plexus reported fiscal second quarter 2025 revenue of $980 million, with a GAAP operating margin of 5.0% and diluted EPS of $1.41[5] - Non-GAAP operating margin for the second quarter was 5.7%, and adjusted diluted EPS was $1.66, excluding $0.25 of stock-based compensation expense[5] - Net sales for the three months ended March 29, 2025, were $980.17 million, a 1.3% increase from $966.90 million for the same period in 2024[20] - Gross profit for the three months ended March 29, 2025, was $97.75 million, compared to $88.06 million for the same period in 2024, reflecting a 10.5% increase[20] - Operating income for the three months ended March 29, 2025, was $48.79 million, up 65.5% from $29.47 million in the same period last year[20] - Net income for the three months ended March 29, 2025, was $39.07 million, significantly higher than $16.24 million for the same period in 2024, representing a 140.5% increase[20] - Basic earnings per share for the three months ended March 29, 2025, were $1.44, compared to $0.59 for the same period in 2024, marking a 144.1% increase[20] - Adjusted operating income for the six months ended March 29, 2025, was $100.33 million, compared to $51.54 million for the same period in 2024[29] - Adjusted diluted earnings per share for the six months ended March 29, 2025, were $3.39, up from $2.42 for the same period in 2024, reflecting a 40.2% increase[24] Guidance and Future Outlook - The company initiated fiscal third quarter 2025 revenue guidance of $1.00 billion to $1.04 billion, with GAAP diluted EPS guidance of $1.40 to $1.55[5] Cash Flow and Capital Management - Free cash flow for the second quarter was $16.5 million, contributing to year-to-date free cash flow of $43.6 million[6] - The cash cycle for the second quarter was 68 days, consistent with the first quarter and showing improvement in inventory management[7] - Return on invested capital (ROIC) for the second quarter was 13.7%, exceeding the weighted average cost of capital by 480 basis points[12] - Return on invested capital (ROIC) for the six months ended March 29, 2025, was 13.7%, compared to 9.9% for the same period in 2024[29] Shareholder Actions - The company repurchased $12.2 million of its shares at an average price of $141.18 per share, with $25 million remaining under the share repurchase authorization[6] Revenue Composition - Revenue from the Aerospace/Defense sector was $172 million, accounting for 18% of total revenue, while Healthcare/Life Sciences contributed $411 million, or 42%[10] - Top 10 customers comprised 51% of revenue during the second quarter, an increase of 3 percentage points from the same quarter in the previous year[9] Balance Sheet Highlights - Total current assets decreased to $2,396.31 million as of March 29, 2025, from $2,477.15 million as of September 28, 2024[22] - Total liabilities decreased to $1,734.07 million as of March 29, 2025, from $1,828.99 million as of September 28, 2024[22]

NEENAH, WI, April 23, 2025 (GLOBE NEWSWIRE) -- Plexus Corp. (NASDAQ: PLXS) today announced financial results for our fiscal second quarter ended March 29, 2025, and guidance for our fiscal third quarter ending June 28, 2025. Reports fiscal second quarter 2025 revenue of $980 million, GAAP operating margin of 5.0% and GAAP diluted EPS of $1.41.Reports fiscal second quarter 2025 non-GAAP operating margin of 5.7% and non-GAAP diluted EPS of $1.66, excluding $0.25 of stock-based compensation expense.Initiates f ...

Plexus Corp (PLXS) is slated to report second-quarter fiscal 2025 earnings on April 23, after the closing bell. The Zacks Consensus Estimate for fiscal second-quarter revenues is pegged at $980.5 million, implying a rise of 1.4% from the year-ago quarter’s reported figure. The consensus mark for earnings per share (EPS) is pegged at $1.54, indicating a 63.8% year-over-year increase. The estimate for the bottom line has remained unchanged in the past 60 days.For second-quarter fiscal 2025, the company expect ...